SCHEMBL6071595

SCHEMBL6071595

N#Cc1c(CC2CCCN2)nc2ccccc2c1N

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.41
HTR6 P50406 6/20 0.41
KDM4E B2RXH2 2/20 0.39
ALDH1A1 P00352 2/20 0.39
MERTK Q12866 1/20 0.37
LMNA P02545 1/20 0.37
TP53 P04637 1/20 0.37
GLA P06280 1/20 0.37
GAA P10253 1/20 0.37
MAPT P10636 1/20 0.37
HPGD P15428 1/20 0.37
TSHR P16473 1/20 0.37
CASP1 P29466 1/20 0.37
HTT P42858 1/20 0.37
RAD52 P43351 1/20 0.37
RAB9A P51151 1/20 0.37
CASP7 P55210 1/20 0.37
KMT2A Q03164 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
HIF1A Q16665 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6071602 0.81 POLB (0.41) POLBHTR6KDM4EALDH1A1MAPT
SCHEMBL6072067 0.73 KDM4E (0.51) POLBKDM4EALDH1A1LMNATP53
SCHEMBL6071634 0.68 KDM4E (0.42) POLBKDM4EALDH1A1LMNATP53
SCHEMBL6071875 0.68 KDM4E (0.42) POLBKDM4EALDH1A1LMNATP53
SCHEMBL6252164 0.68 KDM4E (0.60) POLBKDM4EALDH1A1LMNATP53
SCHEMBL9791332 0.67 ADORA1 (0.62) POLBKDM4EALDH1A1LMNATP53
SCHEMBL27602057 0.67 MAOB (0.44) POLBHTR6KDM4EALDH1A1CYP1A2
SCHEMBL6071415 0.67 KDM4E (0.41) POLBKDM4EALDH1A1LMNATP53
SCHEMBL6072083 0.67 ADRA2A (0.45) POLBKDM4EALDH1A1LMNATP53
SCHEMBL18459144 0.65 KDM4E (0.56) POLBKDM4EALDH1A1LMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060264460-A1 3-Cyanoquinoline inhibitors of Tpl2 kinase and methods of making and using the same WYETH (US) 2006-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060264460-A1 3-Cyanoquinoline inhibitors of Tpl2 kinase and methods of making and using the same TNNI3K, CSNK1A1L, CDKL1 POLB 2825/4885HTR6 4278/4885KDM4E 1032/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.